Novel treatments show potential in addressing hard-to-treat mutations in lung cancer, bringing hope for improved outcomes ArriVent Biopharma recently unveiled ...
First-line treatment shows significant improvement in progression-free survival over pembrolizumab, marking a potential shift in NSCLC care Summit Therapeutics (SMMT) ...
Prioritizes Imaging Radar and Cost-Efficient Solutions for Eyes-Off Systems Mobileye (MBLY), a global leader in autonomous driving technology, has announced ...
AI Leader Faces Intense Scrutiny as Analysts Downgrade Shares Super Micro Computer (SMCI), once hailed as one of the year’s ...
Shareholders Allege Fraud over Downplaying SEC Lawsuit Risks Coinbase (COIN), the largest cryptocurrency exchange in the U.S., faced a significant ...
Revenue Surges 47%, Adjusted EBITDA Reaches 63% of Revenue, and Dividend Declared Broadcom (AVGO), a global leader in semiconductor and ...
FY1Q25 Results Showcase Revenue Beats and Expanding Partnerships Amid Adjustments in Revenue Reporting C3.ai (AI) delivered strong fiscal first-quarter 2025 ...
New Report Highlights Progress and Hurdles in the Push for a National Electric Vehicle Infrastructure The White House has released ...
Targeting Leading IBD Pathways, SYRE Aims to Redefine Efficacy and Convenience with Next-Generation Antibodies SYRE (SYRE), a clinical-stage biopharmaceutical company, ...
In Partnership with Mexico's Liverpool, Nordstrom Aims to Regain Control Amid Sales Challenges Nordstrom's (JWN) founding family has renewed its ...
